Cassava Sciences IncNASDAQ:SAVA
- LAST PRICE19.8500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots20.0000/ 1
- Ask / Lots21.3000/ 1
- Open / Previous Close0.0000 / 19.8500
- Day Range---
- 52 Week Range
- Volume1,351
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAVA |
|---|---|---|
| 09:32 ET | 22019 | 19.86 |
| 09:34 ET | 1505 | 19.9063 |
| 09:36 ET | 7042 | 19.95 |
| 09:38 ET | 7247 | 20 |
| 09:39 ET | 5707 | 20.0666 |
| 09:41 ET | 14120 | 20.1936 |
| 09:43 ET | 2300 | 20.12 |
| 09:45 ET | 8359 | 20.1401 |
| 09:48 ET | 9009 | 20.4 |
| 09:50 ET | 6770 | 20.3828 |
| 09:52 ET | 22108 | 20.54 |
| 09:54 ET | 11324 | 20.7 |
| 09:56 ET | 20428 | 20.63 |
| 09:57 ET | 7551 | 20.5648 |
| 09:59 ET | 1237 | 20.5786 |
| 10:01 ET | 14458 | 20.6177 |
| 10:03 ET | 11689 | 20.6237 |
| 10:06 ET | 4082 | 20.59 |
| 10:08 ET | 3398 | 20.56 |
| 10:10 ET | 1746 | 20.56 |
| 10:12 ET | 16742 | 20.84 |
| 10:14 ET | 9659 | 20.8858 |
| 10:15 ET | 28639 | 21.024 |
| 10:17 ET | 31807 | 21.18 |
| 10:19 ET | 25255 | 21.2256 |
| 10:21 ET | 6628 | 21.22 |
| 10:24 ET | 10334 | 21.1215 |
| 10:26 ET | 28079 | 21.355 |
| 10:28 ET | 6087 | 21.2432 |
| 10:30 ET | 39107 | 21.02 |
| 10:32 ET | 14636 | 21.3 |
| 10:33 ET | 6634 | 21.35 |
| 10:35 ET | 27035 | 21.07 |
| 10:37 ET | 25154 | 20.9676 |
| 10:39 ET | 5522 | 21.015 |
| 10:42 ET | 17916 | 21 |
| 10:44 ET | 9607 | 20.8216 |
| 10:46 ET | 2700 | 20.99 |
| 10:48 ET | 6403 | 20.92 |
| 10:50 ET | 11550 | 20.79 |
| 10:51 ET | 5200 | 20.76 |
| 10:53 ET | 5645 | 20.705 |
| 10:55 ET | 13310 | 20.7 |
| 10:57 ET | 7000 | 20.65 |
| 11:00 ET | 8909 | 20.59 |
| 11:02 ET | 3148 | 20.55 |
| 11:04 ET | 20585 | 20.8199 |
| 11:06 ET | 2737 | 20.85 |
| 11:08 ET | 4496 | 20.85 |
| 11:09 ET | 7622 | 20.89 |
| 11:11 ET | 24409 | 20.7 |
| 11:13 ET | 7170 | 20.5602 |
| 11:15 ET | 3595 | 20.56 |
| 11:18 ET | 1731 | 20.72 |
| 11:20 ET | 3053 | 20.5473 |
| 11:22 ET | 1900 | 20.6 |
| 11:24 ET | 1946 | 20.66 |
| 11:26 ET | 980 | 20.6457 |
| 11:27 ET | 2413 | 20.805 |
| 11:29 ET | 2577 | 20.855 |
| 11:31 ET | 1974 | 20.805 |
| 11:33 ET | 4074 | 20.87 |
| 11:36 ET | 900 | 20.86 |
| 11:38 ET | 1300 | 20.66 |
| 11:40 ET | 1573 | 20.68 |
| 11:42 ET | 8177 | 20.745 |
| 11:44 ET | 8539 | 20.66 |
| 11:45 ET | 2660 | 20.64 |
| 11:47 ET | 2650 | 20.6 |
| 11:49 ET | 3549 | 20.5353 |
| 11:51 ET | 3310 | 20.4449 |
| 11:54 ET | 9038 | 20.45 |
| 11:56 ET | 951 | 20.44 |
| 11:58 ET | 500 | 20.44 |
| 12:00 ET | 6015 | 20.31 |
| 12:02 ET | 4099 | 20.35 |
| 12:03 ET | 875 | 20.3634 |
| 12:05 ET | 1811 | 20.39 |
| 12:07 ET | 2819 | 20.2604 |
| 12:09 ET | 918 | 20.24 |
| 12:12 ET | 4271 | 20.1927 |
| 12:14 ET | 1173 | 20.16 |
| 12:16 ET | 2062 | 20.16 |
| 12:18 ET | 2900 | 20.26 |
| 12:20 ET | 3500 | 20.22 |
| 12:21 ET | 17626 | 20.115 |
| 12:23 ET | 5600 | 20.1499 |
| 12:25 ET | 717 | 20.12 |
| 12:30 ET | 800 | 20.08 |
| 12:32 ET | 736 | 20.12 |
| 12:34 ET | 1480 | 20.2 |
| 12:36 ET | 1540 | 20.27 |
| 12:38 ET | 1500 | 20.24 |
| 12:39 ET | 2431 | 20.1509 |
| 12:41 ET | 200 | 20.15 |
| 12:43 ET | 2996 | 20.1637 |
| 12:45 ET | 1360 | 20.13 |
| 12:48 ET | 900 | 20.12 |
| 12:50 ET | 575 | 20.115 |
| 12:52 ET | 494 | 20.1 |
| 12:54 ET | 5506 | 20.02 |
| 12:56 ET | 1382 | 20.06 |
| 12:57 ET | 1520 | 20.07 |
| 12:59 ET | 600 | 20.03 |
| 01:01 ET | 1400 | 20.04 |
| 01:03 ET | 10444 | 19.9709 |
| 01:06 ET | 3171 | 19.92 |
| 01:08 ET | 3730 | 19.84 |
| 01:10 ET | 3781 | 19.8626 |
| 01:12 ET | 3037 | 19.8527 |
| 01:14 ET | 2460 | 19.94 |
| 01:15 ET | 4301 | 20.01 |
| 01:17 ET | 1650 | 20 |
| 01:19 ET | 4279 | 20.08 |
| 01:21 ET | 4400 | 20.055 |
| 01:24 ET | 2349 | 20.0392 |
| 01:26 ET | 1150 | 19.96 |
| 01:28 ET | 2856 | 19.94 |
| 01:30 ET | 1121 | 19.98 |
| 01:32 ET | 2997 | 19.9588 |
| 01:33 ET | 1260 | 19.885 |
| 01:35 ET | 800 | 19.96 |
| 01:37 ET | 2403 | 19.95 |
| 01:39 ET | 1982 | 19.92 |
| 01:42 ET | 1599 | 19.9728 |
| 01:44 ET | 1543 | 19.95 |
| 01:46 ET | 6561 | 19.86 |
| 01:48 ET | 4508 | 19.86 |
| 01:50 ET | 5091 | 19.84 |
| 01:51 ET | 1680 | 19.87 |
| 01:53 ET | 9029 | 19.81 |
| 01:55 ET | 7354 | 19.745 |
| 01:57 ET | 1682 | 19.7116 |
| 02:00 ET | 4529 | 19.6936 |
| 02:02 ET | 5188 | 19.69 |
| 02:04 ET | 300 | 19.73 |
| 02:06 ET | 600 | 19.77 |
| 02:08 ET | 1930 | 19.839 |
| 02:09 ET | 800 | 19.77 |
| 02:11 ET | 3710 | 19.74 |
| 02:13 ET | 640 | 19.75 |
| 02:15 ET | 1066 | 19.8 |
| 02:18 ET | 1600 | 19.85 |
| 02:20 ET | 1400 | 19.895 |
| 02:24 ET | 300 | 19.93 |
| 02:26 ET | 951 | 19.9 |
| 02:27 ET | 300 | 19.925 |
| 02:29 ET | 900 | 19.9108 |
| 02:31 ET | 5750 | 19.86 |
| 02:33 ET | 290 | 19.89 |
| 02:36 ET | 200 | 19.86 |
| 02:38 ET | 525 | 19.88 |
| 02:40 ET | 600 | 19.87 |
| 02:42 ET | 2563 | 19.84 |
| 02:44 ET | 2306 | 19.77 |
| 02:45 ET | 550 | 19.82 |
| 02:47 ET | 472 | 19.81 |
| 02:49 ET | 1200 | 19.84 |
| 02:51 ET | 501 | 19.8 |
| 02:54 ET | 2227 | 19.8 |
| 02:56 ET | 150 | 19.94 |
| 02:58 ET | 16559 | 19.98 |
| 03:00 ET | 4820 | 20.02 |
| 03:02 ET | 4250 | 20.07 |
| 03:03 ET | 700 | 20.07 |
| 03:05 ET | 10461 | 20.0601 |
| 03:07 ET | 4800 | 20.02 |
| 03:09 ET | 400 | 20 |
| 03:12 ET | 600 | 19.97 |
| 03:14 ET | 3368 | 19.92 |
| 03:16 ET | 425 | 19.95 |
| 03:18 ET | 900 | 19.9859 |
| 03:20 ET | 1638 | 19.92 |
| 03:21 ET | 1319 | 19.91 |
| 03:23 ET | 200 | 19.92 |
| 03:25 ET | 4150 | 19.88 |
| 03:27 ET | 5618 | 19.83 |
| 03:30 ET | 900 | 19.89 |
| 03:32 ET | 1147 | 19.85 |
| 03:34 ET | 600 | 19.86 |
| 03:36 ET | 2944 | 19.86 |
| 03:38 ET | 2550 | 19.81 |
| 03:39 ET | 1300 | 19.79 |
| 03:41 ET | 852 | 19.8356 |
| 03:43 ET | 17290 | 19.93 |
| 03:45 ET | 15798 | 19.93 |
| 03:48 ET | 10982 | 19.93 |
| 03:50 ET | 16616 | 19.76 |
| 03:52 ET | 2025 | 19.87 |
| 03:54 ET | 1407 | 19.91 |
| 03:56 ET | 6946 | 19.865 |
| 03:57 ET | 6189 | 19.865 |
| 03:59 ET | 25507 | 19.85 |
Yesterday
Aug 10, 2022
Bragar Eagel & Squire, P.C. Is Investigating Phathom, TuSimple, Mercury Systems, and Cassava and Encourages Investors to Contact the Firm, from 9:00PM ET on Wednesday Aug 10, 2022 by GlobeNewswire
9:00PM ET on Wednesday Aug 10, 2022 by GlobeNewswire
Aug 3, 2022
Cassava Sciences Q2 Loss Widens, from 10:15AM ET on Wednesday Aug 03, 2022 by MT Newswires
10:15AM ET on Wednesday Aug 03, 2022 by MT NewswiresBRIEF-Cassava Sciences Reports Second Quarter Financial Results For 2022, from 9:16AM ET on Wednesday Aug 03, 2022 by Thomson Reuters
9:16AM ET on Wednesday Aug 03, 2022 by Thomson ReutersCassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study, from 9:15AM ET on Wednesday Aug 03, 2022 by GlobeNewswire
9:15AM ET on Wednesday Aug 03, 2022 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cassava Sciences Inc | 794.7M | -13.1x | --- |
POINT Biopharma Global Inc | 811.1M | -12.9x | --- |
Compass Pathways PLC | 839.0M | -8.7x | --- |
Relmada Therapeutics Inc | 878.1M | -3.9x | --- |
Instil Bio Inc | 859.8M | -4.7x | --- |
Anavex Life Sciences Corp | 903.4M | -19.0x | --- |
Company Information
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimer's disease. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer's brain. The SavaDx, is an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is also developing SavaDx is a quantitative blood-based investigational biomarker/diagnostic to detect and monitor Alzheimer's disease. The Company’s scientific approach for the treatment of Alzheimer's disease seeks to simultaneously progress both neurodegeneration and neuroinflammation.
Contact Information
- Headquarters
- 7801 N Capital of Texas Hwy Ste 260AUSTIN, TX, United States 78731-1192
- Phone
- 512-501-2444
- Fax
- 512-614-0414
Executives
- Chairman of the Board, President, Chief Executive Officer
- Remi Barbier
- Chief Financial Officer
- Eric Schoen
- Chief Medical Officer, Director
- Nadav Friedmann
- Chief Clinical Development Officer
- James Kupiec
- Lead Independent Director
- Sanford Robertson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $794.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 40.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.69 |
EPS | $-1.52 |
Book Value | $6.35 |
P/E Ratio | -13.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
